NLRP3 Inflammasome Mediated Interleukin-1β Production in Cancer-Associated Fibroblast Contributes to ALA-PDT for Cutaneous Squamous Cell Carcinoma

References

• Henderson BW, Gollnick SO, Snyder JW, et al. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res. 2004;64:2120–2126. doi:10.1158/0008-5472.CAN-03-351315026352
   PubMed Web of Science ®Google Scholar
• Togsverd-Bo K, Lerche CM, Philipsen PA, et al. Artificial daylight photodynamic therapy with “non-inflammatory” doses of hexyl aminolevulinate only marginally delays SCC development in UV-exposed hairless mice. Photochem Photobiol Sci. 2013;12:2130–2136. doi:10.1039/c3pp50152c24064675
   PubMed Web of Science ®Google Scholar
• Brackett CM, Gollnick SO. Photodynamic therapy enhancement of anti-tumor immunity. Photochem Photobiol Sci. 2011;10:649–652. doi:10.1039/c0pp00354a21253659
   PubMed Web of Science ®Google Scholar
• Kousis PC, Henderson BW, Maier PG, et al. Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils. Cancer Res. 2007;67:10501–10510. doi:10.1158/0008-5472.CAN-07-177817974994
   PubMed Web of Science ®Google Scholar
• Chen J, Huang JH, Wang Z, et al. Endoplasmic reticulum stress-mediated autophagy contributes to 5-ethylamino- 9 - diethylaminobenzo [a] phenoselenazinium - mediated photodynamic therapy via the PERK-eIF2α pathway. Onco Targets Ther. 2018;24:4315–4325. doi:10.2147/OTT.S163366
   Google Scholar
• Gollnick SO. Photodynamic therapy and antitumor immunity. J Natl Compr Canc Netw. 2012;10 Suppl 2:S40–S43. doi:10.6004/jnccn.2012.017323055214
   PubMed Web of Science ®Google Scholar
• Firczuk M, Nowis D, Golab J. PDT-induced inflammatory and host responses. Photochem Photobiol Sci. 2011;10:653–663. doi:10.1039/c0pp00308e21258727
   PubMed Web of Science ®Google Scholar
• Korbelik M. PDT-associated host response and its role in the therapy outcome. Lasers Surg Med. 2006;38:500–508. doi:10.1002/(ISSN)1096-910116634073
   PubMed Web of Science ®Google Scholar
• Jimenez Fernandez D, Lamkanfi M. Inflammatory caspases: key regulators of inflammation and cell death. Biol Chem. 2015;396:193–203. doi:10.1515/hsz-2014-025325389992
   PubMed Web of Science ®Google Scholar
• Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007;14:10–22. doi:10.1038/sj.cdd.440203816977329
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550. doi:10.1146/annurev.immunol.021908.13261219302047
   PubMed Web of Science ®Google Scholar
• Dinarello CA. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol. 2011;41:1203–1217. doi:10.1002/eji.20114155021523780
   PubMed Web of Science ®Google Scholar
• Abderrazak A, Syrovets T, Couchie D, et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biol. 2015;4:296–307. doi:10.1016/j.redox.2015.01.00825625584
   PubMed Web of Science ®Google Scholar
• Stehlik C, Lee SH, Dorfleutner A, et al. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol. 2003;171:6154–6163. doi:10.4049/jimmunol.171.11.615414634131
   PubMed Web of Science ®Google Scholar
• Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582–598.27550820
   PubMed Web of Science ®Google Scholar
• Wang X, Ji J, Zhang H, et al. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells. Oncotarget. 2015;6:44688–44702. doi:10.18632/oncotarget.v6i4226625309
   PubMedGoogle Scholar
• Cole CA, Davies RE, Forbes PD, et al. Comparison of action spectra for acute cutaneous responses to ultraviolet radiation: man and albino hairless mouse. Photochem Photobiol. 1983;37:623–631. doi:10.1111/php.1983.37.issue-66611669
   PubMed Web of Science ®Google Scholar
• Henderson BW, Waldow SM, Mang TS, et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 1985;45:572–576.3967232
   PubMed Web of Science ®Google Scholar
• Mueller L, Goumas FA, Affeldt M, et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol. 2007;171:1608–1618. doi:10.2353/ajpath.2007.06066117916596
   PubMed Web of Science ®Google Scholar
• Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev. 2009;19:67–73. doi:10.1016/j.gde.2009.01.00319211240
   PubMed Web of Science ®Google Scholar
• Erez N, Truitt M, Olson P, et al. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell. 2010;17:135–147. doi:10.1016/j.ccr.2009.12.04120138012
   PubMed Web of Science ®Google Scholar
• Bussard KM, Mutkus L, Stumpf K, et al. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18:84. doi:10.1186/s13058-016-0740-227515302
   PubMed Web of Science ®Google Scholar
• Servais C, Erez N. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation. J Pathol. 2013;229:198–207. doi:10.1002/path.410322996812
   PubMed Web of Science ®Google Scholar
• Harper J, Sainson RC. Regulation of the anti-tumour immune response by cancer-associated fibroblasts. Semin Cancer Biol. 2014;25:69–77. doi:10.1016/j.semcancer.2013.12.00524406209
   PubMed Web of Science ®Google Scholar
• Theodoraki MN, Lorenz K, Lotfi R, et al. Influence of photodynamic therapy on peripheral immune cell populations and cytokine concentrations in head and neck cancer. Photodiagnosis Photodyn Ther. 2017;19:194–201. doi:10.1016/j.pdpdt.2017.05.01528578124
   PubMed Web of Science ®Google Scholar
• Lewis AM, Varghese S, Xu H, et al. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med. 2006;4:48. doi:10.1186/1479-5876-4-4817096856
   PubMed Web of Science ®Google Scholar
• Wei Q, Mu K, Li T, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 2014;94:52–62. doi:10.1038/labinvest.2013.12624166187
   PubMed Web of Science ®Google Scholar